Compare CMRC & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMRC | KRMD |
|---|---|---|
| Founded | 2009 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.9M | 192.5M |
| IPO Year | 2020 | 2019 |
| Metric | CMRC | KRMD |
|---|---|---|
| Price | $2.20 | $3.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $4.88 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 1.0M | 229.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.43 | ★ 53.85 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $342,349,000.00 | $41,127,366.00 |
| Revenue This Year | $5.11 | $20.32 |
| Revenue Next Year | $4.50 | $17.37 |
| P/E Ratio | $37.00 | ★ N/A |
| Revenue Growth | 2.83 | ★ 22.23 |
| 52 Week Low | $1.95 | $3.21 |
| 52 Week High | $5.55 | $6.61 |
| Indicator | CMRC | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.54 | 31.02 |
| Support Level | $1.95 | $3.21 |
| Resistance Level | $3.16 | $4.27 |
| Average True Range (ATR) | 0.19 | 0.22 |
| MACD | -0.11 | -0.08 |
| Stochastic Oscillator | 16.61 | 10.96 |
Commerce.com Inc is engaged in offering a Software-as-a-Service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which the majority of its revenue is generated from Americas-U.S.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.